Acumen Pharmaceuticals, Inc. (“Acumen”) (NASDAQ: ABOS) today announced the pricing of an upsized underwritten public offering of 16,774,193 shares of its common stock at a price to the public of $7.75 per share.
Acumen Pharmaceuticals, Inc. (“Acumen”) (NASDAQ: ABOS) today announced the pricing of an upsized underwritten public offering of 16,774,193 shares of its common stock at a price to the public of $7.75 per share.